SCHEMBL30959751

SCHEMBL30959751

CCC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.63
▸ KDM4E B2RXH2 2/20 0.63
▸ MEN1 O00255 2/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ AKR1B10 O60218 1/20 0.63
▸ ACHE P22303 2/20 0.37
▸ CYP3A4 P08684 3/20 0.35
▸ PTGES O14684 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ SLC6A2 P23975 2/20 0.35
▸ SLC6A4 P31645 2/20 0.35
▸ SLC6A3 Q01959 2/20 0.35
▸ PTPN1 P18031 2/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ DLAT P10515 1/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ SIRT1 Q96EB6 1/20 0.35
▸ FASN P49327 3/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL819253 0.89 ALOX5 (0.78) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL6271205 0.87 ALOX5 (0.61) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL29405771 0.85 ALOX5 (0.57) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL817774 0.83 ALOX5 (0.53) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL26468487 0.83 ALOX5 (0.55) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL23155161 0.82 ALOX5 (0.61) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL316240 0.82 ALOX5 (0.56) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL31576807 0.81 MEN1 (0.54) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL31576822 0.81 ALOX5 (0.53) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL13922241 0.79 ALOX5 (0.52) ALOX5KDM4EMEN1KMT2AAKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623074-A1 RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS Epimeron USA, Inc. (US) 2025-10-01 — — EP claimed
US-20250270598-A1 RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS EPIMERON USA, INC. (US) 2025-08-28 — — US claimed
WO-2024112694-A1 RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS WILLOW BIOSCIENCES, INC. (CA) 2024-05-30 — — WO claimed
EP-4623074-A1 RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS Epimeron USA, Inc. (US) 2025-10-01 — — EP disclosed
US-20250270598-A1 RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS EPIMERON USA, INC. (US) 2025-08-28 — — US disclosed
WO-2025104281-A1 HOP DERIVED COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY CORONAVIRUSES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-05-22 — — WO disclosed
EP-4556004-A1 HOP DERIVED COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY CORONAVIRUSES Centre National de la Recherche Scientifique (FR) 2025-05-21 — — EP disclosed
WO-2024112694-A1 RECOMBINANT POLYPEPTIDES WITH PRENYLTRANSFERASE ACTIVITY FOR BIOSYNTHESIS OF CANNABINOIDS AND HOP COMPOUNDS WILLOW BIOSCIENCES, INC. (CA) 2024-05-30 — — WO disclosed
Send feedback